These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 9406779)
1. Trypanosoma cruzi: effect of immunization on the risk of vector-delivered infection in guinea pigs. Basombrío MA; Nasser JR; Segura MA; Gomez LE J Parasitol; 1997 Dec; 83(6):1059-62. PubMed ID: 9406779 [TBL] [Abstract][Full Text] [Related]
2. Vectorial transmission of Trypanosoma cruzi: an experimental field study with susceptible and immunized hosts. Catala SS; Gorla DE; Basombrio MA Am J Trop Med Hyg; 1992 Jul; 47(1):20-6. PubMed ID: 1636879 [TBL] [Abstract][Full Text] [Related]
3. [Immunologic protection against Chagas disease. Independent effects upon infection, dissemination and lesions of Trypanosoma cruzi]. Basombrio MA; Mora MC; Segura MA Medicina (B Aires); 1989; 49(3):191-6. PubMed ID: 2518641 [TBL] [Abstract][Full Text] [Related]
5. Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2. Duan X; Yonemitsu Y; Chou B; Yoshida K; Tanaka S; Hasegawa M; Tetsutani K; Ishida H; Himeno K; Hisaeda H Vaccine; 2009 Oct; 27(44):6154-9. PubMed ID: 19712768 [TBL] [Abstract][Full Text] [Related]
6. Trypanosoma cruzi: partial prevention of the natural infection of guinea pigs with a killed parasite vaccine. Basombrio MA Exp Parasitol; 1990 Jul; 71(1):1-8. PubMed ID: 2113004 [TBL] [Abstract][Full Text] [Related]
7. Protective effect of Trypanosoma rangeli against infections with a highly virulent strain of Trypanosoma cruzi. Zuñiga C; Palau T; Penin P; Gamallo C; de Diego JA Trop Med Int Health; 1997 May; 2(5):482-7. PubMed ID: 9217704 [TBL] [Abstract][Full Text] [Related]
8. Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Trypanosoma cruzi infection: a vaccine candidate. Fontanella GH; De Vusser K; Laroy W; Daurelio L; Nocito AL; Revelli S; Contreras R Vaccine; 2008 May; 26(19):2322-34. PubMed ID: 18403070 [TBL] [Abstract][Full Text] [Related]
9. Trypanosoma cruzi infection from the view of CD8+ T cell immunity--an infection model for developing T cell vaccine. Miyahira Y Parasitol Int; 2008 Mar; 57(1):38-48. PubMed ID: 17728174 [TBL] [Abstract][Full Text] [Related]
10. Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice. Basso B; Cervetta L; Moretti E; Carlier Y; Truyens C Vaccine; 2004 May; 22(15-16):1868-72. PubMed ID: 15121297 [TBL] [Abstract][Full Text] [Related]
11. Gene-deleted live-attenuated Trypanosoma cruzi parasites as vaccines to protect against Chagas disease. Sánchez-Valdéz FJ; Pérez Brandán C; Ferreira A; Basombrío MÁ Expert Rev Vaccines; 2015 May; 14(5):681-97. PubMed ID: 25496192 [TBL] [Abstract][Full Text] [Related]
12. Chagas disease control: deltamethrin-treated collars reduce Triatoma infestans feeding success on dogs. Reithinger R; Ceballos L; Stariolo R; Davies CR; Gürtler RE Trans R Soc Trop Med Hyg; 2005 Jul; 99(7):502-8. PubMed ID: 15869774 [TBL] [Abstract][Full Text] [Related]
13. Infestin 1R, an intestinal subtilisin inhibitor from Triatoma infestans able to impair mammalian cell invasion by Trypanosoma cruzi. Lovato DV; Amino R; González Y; Miranda A; Schenkman S; Tanaka AS Exp Parasitol; 2011 Dec; 129(4):362-7. PubMed ID: 21963772 [TBL] [Abstract][Full Text] [Related]
15. Protection against Trypanosoma cruzi using fecal forms of homologous parasites from juvenilized or normal vectors of Chagas' disease and by passive transfer of immune blood. Perlowagora-Szumlewicz A Rev Bras Malariol Doencas Trop; 1977; 29():5-21. PubMed ID: 120952 [No Abstract] [Full Text] [Related]
16. Protective immunity against Trypanosoma cruzi provided by oral immunization with Phytomonas serpens: role of nitric oxide. Pinge-Filho P; Peron JP; de Moura TR; Menolli RA; Graça VK; Estevão D; Tadokoro CE; Jankevicius JV; Rizzo LV Immunol Lett; 2005 Jan; 96(2):283-90. PubMed ID: 15585334 [TBL] [Abstract][Full Text] [Related]
17. [Kinetics of the humoral immune response in mice immunized against and inoculated with Trypanosoma cruzi]. Licón-Trillo A; Pérez-Reyes R Rev Latinoam Microbiol; 1994; 36(2):119-25. PubMed ID: 7973179 [TBL] [Abstract][Full Text] [Related]
18. Antibodies from Chagas patients serum bind to the gut epithelial cell surface of Triatoma infestans. Gutierrez LS; Burgos MH; Brengio SD Microsc Electron Biol Celular; 1991 Dec; 15(2):145-57. PubMed ID: 1844359 [TBL] [Abstract][Full Text] [Related]
19. [Evaluation of the impact of vector control of Chagas disease through serological testing in Mambaí/Buritinópolis, Goiás State]. Peñaranda-Carrillo R; Moreira EF; Silveira AC; Leite J; Vinhaes MC; Castro C; Macêdo V Rev Soc Bras Med Trop; 2002; 35(4):331-8. PubMed ID: 12170328 [TBL] [Abstract][Full Text] [Related]
20. Survey for Trypanosoma cruzi infection in a municipality in northeast Brazil. Tachibana H; Paz KC; Landivar WH; Kobayashi S; Montenegro LT; Figuerêdo-Silva J; Tateno S Tokai J Exp Clin Med; 1999 Oct; 24(3):131-6. PubMed ID: 10733161 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]